“Torus Pharma has introduced three MRP products to the local market in under a year, supporting sustained market growth while effectively managing regulatory and market access activities.”
“Torus Pharma has been our trusted partner for over 10 years, managing the full launch of new Yttrium-90 (Y-90) indications for selective internal radiation therapy (SIRT) and ensuring patients’ access to minimally invasive, effective, and modern treatments.”
“Together with Torus Pharma since 2025, Cyclolux has achieved rapid market growth in Romania, with Torus Pharma facilitating market access and active promotion within the healthcare system.”
